cTAP at the 2021 PPMD Duchenne Drug Development Roundtable

James Signorovitch and Susan Ward presented at the 2021 PPMD Duchenne Drug Development Roundtable. James’s presentation is entitled “Considerations for Industry and Regulators” and Susan’s is entitled “Modeling Duchenne: Natural History and Real-World Data”

cTAP at the 2021 RE(ACT) CONGRESS and IRDIRC Conference

Susan J. Ward presents at the RE(ACT) CONGRESS and IRDIRC Conference. The talk is entitled “Learning from natural history patient data to drive smaller, faster, trials – a case study in Duchenne Muscular Dystrophy (DMD).” View the PDF Abstract

cTAP at the 2018 ISPOR Conference

May 2018 James Signorovitch presented at the 2018 ISPOR Conference. The presentation is entitled “Ambulatory function in Duchenne muscular dystrophy; The characteristic trajectory and variation across individuals.” View the Full PDF

cTAP at the 2017 IRDiRC Conference

February 2017 Susan J. Ward presented at IRDiRC Conference 2017. The presentation is entitled “Translating Natural History into Clinical Trial Design, Lessons from Duchenne.” View the Full PDF

cTAP at the World Congress Orphan Disease Conference 2015

November 2015 Susan J. Ward presented at the World Congress Orphan Disease Conference 2015. The presentation is entitled “Enabling the right trial design, the first time; Supporting new therapies to patients sooner.” View the Full PDF

cTAP at the 2015 PPMD Conference

June 2015 James Signorovitch presented at the 2015 PPMD Conference. The presentation is entitled “The Collaborative Trajectory Analysis Project (cTAP); Explaining variation in Duchenne disease progression to accelerate drug development.” View the Full PDF